Home News Company News Launch date Title 2015-06-08 arigo NFkB Signalling Pathway products. 2015-06-04 Featuring arigo’s Biogenic Amine ELISA Kits 2015-05-29 14-3-3η as a promising target for the treatment of Major Depression Disorder 2015-05-13 Blame your brain for not sticking to a diet plan 2015-04-30 JunB as a novel gate keeper for prostate cancer progression 2015-04-24 Organelle marker 2015-04-16 PDGF-BB induces angiogenesis during coupling with osteogenesis 2015-04-08 A new purpose: Sox2 has more to offer in the immune system 2015-03-06 arigo is attending the 2015 Conference of Chinese Society for Cell Biology (CSCB) in ShenZhen 2015-03-05 TGF-beta responding cancer stem cells: The culprit for metastasis and anti-cancer drug resistance 2015-02-24 Dopamine packaging protects brain damage in Parkinson’s model 2015-02-11 TIGIT and PD-1 combinatorial therapy: One step closer to effective anti-cancer drug 2015-01-30 “Satiety hormone” Leptin links obesity to high blood pressure 2015-01-12 Quality ELISA Kits for the profiling of cytokines released by CD4+ T Cells 2015-01-07 The missing link between Circadian Rhythm and Learning Memory 2014-12-23 “Good Fat” Protects Against Diabetes and Obesity in Humans 2014-11-17 Young blood reverses aging 2014-11-03 Study Report: Mechanism of neuronal gene repression in Alzheimer’s Diseases revealed. 2014-10-24 Study Report: mTOR Ser-2448 phosphorylation induces cancer progression through Bid pathway 2014-09-16 New cancer metabolism antibodies FirstPrevious5678Next
